Congress expands HIV prevention funding to include PrEP globally
H.R. 4627 — To amend the Foreign Assistance Act of 1961 to modify treatment activities for assistance to combat HIV/AIDS. · Filed by Yassamin Ansari (D-AZ) · 18 cosponsors · Introduced Jul 23, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the Foreign Assistance Act of 1961 to expand what counts as core HIV/AIDS prevention assistance eligible for U.S. foreign aid funding. It adds HIV pre-exposure prophylaxis (PrEP) medications to the list of covered prevention activities, designates prevention efforts as 'core life-saving humanitarian assistance,' and clarifies that prevention work targeting at-risk populations (as defined by the World Health Organization) qualifies for funding.
Why we flagged it
The bill's operative mechanism is straightforward: it expands the definition of eligible HIV/AIDS prevention activities under foreign aid law to include PrEP and designates prevention as core humanitarian assistance. This is a technical amendment to broaden funding eligibility for evidence-based prevention tools.
What the text implies
- Designating prevention as 'core life-saving humanitarian assistance' may increase budget priority and protection from appropriations cuts compared to other foreign aid categories.
- WHO-based designation of at-risk populations could shift targeting away from country-specific or donor-preference-driven allocation toward epidemiologically-driven distribution.
The full analysis lists 3 implications of this text.
Who stands to gain
generic pharmaceutical manufacturers (PrEP production); international health NGOs and implementing partners; public health organizations receiving prevention funding